CashuBayer AG Partners with Kumquat to Develop KRAS G12D Cancer Treatment Inhibitorabout 23 hours ago
CashuBayer AG Collaborates with K36 Therapeutics on Clinical Development of KTX-2001 for Cancer Treatment5 days ago